Sylvie Labrouche

Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement

Geneviève Freyburger, G. Maçouillard, Sylvie Labrouche et al. · Thrombosis Research · 2011 · 156 citations

Medicine, Orthopedic Surgery, Surgery +17

D-dimer strategy in thrombosis exclusion--a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared.

G. Freyburger, Hervé Trillaud, Sylvie Labrouche et al. · PubMed · 1998 · 141 citations

Medicine, Hematology, Internal Medicine +17

D-dimer Strategy in Thrombosis Exclusion

Hervé Trillaud, Sylvie Labrouche, P Gauthier et al. · Thrombosis and Haemostasis · 1998 · 105 citations

Medicine, Hematology, Internal Medicine +14

Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat.

M. Allard, Sylvie Labrouche, Anne Nosjean et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 63 citations

Medicine, Neurobiology, Pharmacology +15

Mild Hyperhomocysteinemia and Hemostatic Factors in Patients with Arterial Vascular Diseases

G. Freyburger, Sylvie Labrouche, Gérard Sassoust et al. · Thrombosis and Haemostasis · 1997 · 51 citations

Medicine, Cardiology, Hematology +16